WCWanqi Chen

Wanqi Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wanqi Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Optimization analysis based on the preparation of C4 olefin process

    by Wanqi Chen, Xingyu Ma, Mengtong Li

    In this paper, the influencing factors in the preparation process of C4 olefins were studied, and the suitable temperature and catalyst combinations were selected by optimization. The relationship between ethanol conversion and C4 olefin selectivity and the temperature was obtained by least squares fitting, and the model has good accuracy. A multiple regression model was developed to optimize the catalyst combinations under two charging methods A and B with the objective function of maximizing the C4 yield, and the optimal combinations of parameters were obtained for different charging methods and temperatures to provide a reference for the production process.

  • Effects of oncolytic viruses and viral vectors on immunity in glioblastoma

    by Penghao Liu, Yaning Wang, Yuekun Wang, Ziren Kong, Wanqi Chen, Jiatong Li, Wenlin Chen, Yuanren Tong, Wenbin Ma, Yu Wang

    Glioblastoma (GBM) is regarded as an incurable disease due to its poor prognosis and limited treatment options. Virotherapies were once utilized on cancers for their oncolytic effects. And they are being revived on GBM treatment, as accumulating evidence presents the immunogenic effects of virotherapies in remodeling immunosuppressive GBM microenvironment. In this review, we focus on the immune responses induced by oncolytic virotherapies and viral vectors in GBM. The current developments of GBM virotherapies are briefly summarized, followed by a detailed depiction of their immune response. Limitations and lessons inferred from earlier experiments and trials are discussed. Moreover, we highlight the importance of engaging the immune responses induced by virotherapies into the multidisciplinary management of GBM.